S 1000/HR 2377, Saving Access to Laboratory Services Act
Duration: July 1, 2011
to
December 31, 2023
General Issues: Medicare/Medicaid , Health Issues , Medical/Disease Research/Clinical Labs , Government Issues
Spending: about $1,830,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2011: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Office of Science & Technology Policy (OSTP), White House Office, Health & Human Services - Dept of (HHS), Equal Employment Opportunity Commission (EEOC), Health & Human Services - Dept of (HHS), Patent & Trademark Office (PTO), Agency for Health Care Policy & Research, Centers For Medicare and Medicaid Services (CMS),, Natl Institute of Standards & Technology (NIST)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2023
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on Jan. 30.
Original Filing: 301542402.xml
Lobbying Issues
S 1000/HR 2377, Saving Access to Laboratory Services Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. terminated an engagement in which they represented Association for Molecular Pathology on Jan. 30.
Original Filing: 301542403.xml
Lobbying Issues
S 1000/HR 2377, Saving Access to Laboratory Services Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on Oct. 23, 2023.
Original Filing: 301517338.xml
Lobbying Issues
S 1000/HR 2377, Saving Access to Laboratory Services Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on July 20, 2023.
Original Filing: 301488125.xml
Lobbying Issues
S 642/HR 1780, Finn Sawyer Access to Cancer Testing Act; S 1000/HR 2377, Saving Access to Laboratory Services Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on April 17, 2023.
Original Filing: 301453396.xml
Lobbying Issues
coverage for new technologies
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on Jan. 17, 2023.
Original Filing: 301429326.xml
Lobbying Issues
Coverage for new technologies
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. did no lobbying for Association for Molecular Pathology . The report was filed on Oct. 20, 2022.
Original Filing: 301417368.xml
2nd Quarter, 2022
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on July 18, 2022.
Original Filing: 301382974.xml
Lobbying Issues
Telehealth Extension and Evaluation Act (S.3593/HR 7583)
Education on the value of molecular diagnostics
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2022
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on April 20, 2022.
Original Filing: 301367851.xml
Lobbying Issues
Telehealth Extension and Evaluation Act (S.3593)
4th Quarter, 2021
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. did no lobbying for Association for Molecular Pathology . The report was filed on Jan. 20, 2022.
Original Filing: 301337387.xml
3rd Quarter, 2021
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. did no lobbying for Association for Molecular Pathology . The report was filed on Oct. 20, 2021.
Original Filing: 301309617.xml
2nd Quarter, 2021
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. did no lobbying for Association for Molecular Pathology . The report was filed on July 20, 2021.
Original Filing: 301286345.xml
1st Quarter, 2021
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on April 16, 2021.
Original Filing: 301254458.xml
Lobbying Issues
Medicare Multi-Cancer Early Detection Screening Coverage Act
Rare Cancer Awareness, Research and Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. did no lobbying for Association for Molecular Pathology . The report was filed on Jan. 19, 2021.
Original Filing: 301235121.xml
3rd Quarter, 2020
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on Oct. 19, 2020.
Original Filing: 301216469.xml
Lobbying Issues
Coverage and reimbursement for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2020
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on July 16, 2020.
Original Filing: 301189087.xml
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
National Coverage Determination for Next Generation Sequencing
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2020
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on June 2, 2020.
Original Filing: 301183841.xml
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
National Coverage Determination for Next Generation Sequencing
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2019
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on Jan. 15, 2020.
Original Filing: 301106221.xml
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
National Coverage Determination for Next Generation Sequencing
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2019
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on Oct. 15, 2019.
Original Filing: 301065668.xml
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
National Coverage Determination for Next Generation Sequencing
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2019
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $20,000. The report was filed on July 9, 2019.
Original Filing: 301043636.xml
Lobbying Issues
Regulation of laboratory diagnostics
HR 5062, Advancing Access to Precision Medicine Act
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
National Coverage Determination for Next Generation Sequencing
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2019
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $40,000. The report was filed on April 17, 2019.
Original Filing: 301026703.xml
Lobbying Issues
Regulation of laboratory diagnostics
HR 5062, Advancing Access to Precision Medicine Act
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
National Coverage Determination for Next Generation Sequencing
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2018
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on Jan. 22, 2019.
Original Filing: 301015752.xml
Lobbying Issues
Regulation of laboratory diagnostics
No bill number, Diagnostic Accuracy and Innovation Act
HR 5062, Advancing Access to Precision Medicine Act
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2018
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on Oct. 19, 2018.
Original Filing: 300990299.xml
Lobbying Issues
Regulation of laboratory diagnostics
No bill number, Diagnostic Accuracy and Innovation Act
HR 5062, Advancing Access to Precision Medicine Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2018
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on July 18, 2018.
Original Filing: 300967572.xml
Lobbying Issues
Regulation of laboratory diagnostics
No bill number, Diagnostic Accuracy and Innovation Act
HR 5062, Advancing Access to Precision Medicine Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2018
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on April 17, 2018.
Original Filing: 300945681.xml
Lobbying Issues
Regulation of laboratory diagnostics
No bill number, Diagnostic Accuracy and Innovation Act
HR 5062, Advancing Access to Precision Medicine Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2017
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on Jan. 22, 2018.
Original Filing: 300933956.xml
Lobbying Issues
Regulation of laboratory diagnostics
No bill number, Diagnostic Accuracy and Innovation Act
No bill number, Advancing Access to Precision Medicine Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2017
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on Oct. 18, 2017.
Original Filing: 300907361.xml
Lobbying Issues
Regulation of laboratory diagnostics
No bill number, Diagnostic Accuracy and Innovation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2017
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on July 19, 2017.
Original Filing: 300888576.xml
Lobbying Issues
Regulation of laboratory diagnostics
No bill number, Diagnostic Accuracy and Innovation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
HR 1313 Preserving Employee Wellness Program Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2017
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on April 18, 2017.
Original Filing: 300867802.xml
Lobbying Issues
Precision Medicine Initiative
Regulation of laboratory diagnostics
Cancer Moonshot
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 114-255, 21st Century Cures Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
HR 1313 Preserving Employee Wellness Program Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2016
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on Jan. 18, 2017.
Original Filing: 300848302.xml
Lobbying Issues
Precision Medicine Initiative
Regulation of laboratory diagnostics
Cancer Moonshot
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Public Law No. 114-255, 21st Century Cures Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2016
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on Oct. 19, 2016.
Original Filing: 300831827.xml
Lobbying Issues
Precision Medicine Initiative
Regulation of laboratory diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 6, 21st Century Cure Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2016
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on July 19, 2016.
Original Filing: 300814741.xml
Lobbying Issues
Precision Medicine Initiative
Regulation of laboratory diagnostics
Public Law 110-343, Genetic Information Nondiscrimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office Equal Employment Opportunity Commission (EEOC) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 6, 21st Century Cure Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Coverage and reimbursement for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Equal Employment Opportunity Commission (EEOC)
1st Quarter, 2016
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on April 13, 2016.
Original Filing: 300790482.xml
Lobbying Issues
Precision Medicine Initiative
Regulation of laboratory diagnostics
Public Law 110-343, Genetic Information Nondiscrimination Act
Federal Policy for the Protection of Human Subject (Common Rule)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office Equal Employment Opportunity Commission (EEOC) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 6, 21st Century Cure Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
S. 620/HR. 1189, Preserving Employee Wellness Programs Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Equal Employment Opportunity Commission (EEOC)
4th Quarter, 2015
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $50,000. The report was filed on Jan. 21, 2016.
Original Filing: 300784674.xml
Lobbying Issues
Precision Medicine Initiative
Regulation of laboratory diagnostics
Public Law 110-343, Genetic Information Nondiscrimination Act
Federal Policy for the Protection of Human Subject (Common Rule)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office Equal Employment Opportunity Commission (EEOC) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 6, 21st Century Cure Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
S. 620/HR. 1189, Preserving Employee Wellness Programs Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Equal Employment Opportunity Commission (EEOC)
3rd Quarter, 2015
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $50,000. The report was filed on Oct. 15, 2015.
Original Filing: 300753727.xml
Lobbying Issues
Precision Medicine Initiative
Regulation of laboratory diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 6, 21st Century Cure Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
S. 620/HR. 1189, Preserving Employee Wellness Programs Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Equal Employment Opportunity Commission (EEOC)
Lobbying Issues
Federal employee travel restrictions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $50,000. The report was filed on July 15, 2015.
Original Filing: 300734694.xml
Lobbying Issues
Precision Medicine Initiative
Regulation of laboratory diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 6, 21st Century Cure Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
S. 620/HR. 1189, Preserving Employee Wellness Programs Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Equal Employment Opportunity Commission (EEOC)
Lobbying Issues
Federal employee travel restrictions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $50,000. The report was filed on April 15, 2015.
Original Filing: 300715666.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
no bill #, 21st Century Cure Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Federal employee travel restrictions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of Association for Molecular Pathology in Q12015 on April 15, 2015.
Original Filing: 300716270.xml
Lobbying Issues
Precision Medicine Initiative
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP) White House Office
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
no bill #, 21st Century Cure Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Federal employee travel restrictions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2014
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on Jan. 16, 2015.
Original Filing: 300698716.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1309, Health Information Technology Reform Act
HR 2085, Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
HR 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 313, Government Spending Accountability Act/S. 1347 Conference Accountability Act of 2013
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2014
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of Association for Molecular Pathology in Q32014 on Jan. 16, 2015.
Original Filing: 300698701.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1309, Health Information Technology Reform Act
HR 2085, Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
HR 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 313, Government Spending Accountability Act/S. 1347 Conference Accountability Act of 2013
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2014
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $60,000. The report was filed on Oct. 16, 2014.
Original Filing: 300677536.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1309, Health Information Technology Reform Act
HR 2085, Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
HR 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 313, Government Spending Accountability Act/S. 1347 Conference Accountability Act of 2013
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $40,000. The report was filed on July 14, 2014.
Original Filing: 300656290.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1309, Health Information Technology Reform Act
HR 2085, Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
HR 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 313, Government Spending Accountability Act/S 1347 Conference Accountability Act of 2013
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2014
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on April 11, 2014.
Original Filing: 300634570.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues.
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues.
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013HR 4302 Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Agency for Health Care Policy & Research Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
H.R. 313 Government Spending Accountability Act/ S. 1347 Conference Accountability Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2013
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on Jan. 10, 2014.
Original Filing: 300612611.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues.
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues.
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R. 313 Government Spending Accountability Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2013
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on Oct. 17, 2013.
Original Filing: 300595671.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act;
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act;
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Lobbying Issues
H.R. 313 Government Spending Accountability Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2013
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on July 17, 2013.
Original Filing: 300574246.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care;
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act;
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Lobbying Issues
H.R. 313 Government Spending Accountability Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2013
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on April 17, 2013.
Original Filing: 300551503.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care;
HR 1309: Health Information Technology Reform Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act;
HR 1309: Health Information Technology Reform Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Lobbying Issues
H.R. 313 Government Spending Accountability Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2012
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on Jan. 16, 2013.
Original Filing: 300530180.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
HR6446, Improving Diagnostic Innovations Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
HR6446, Improving Diagnostic Innovations Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Lobbying Issues
S.A. 2060 Government Sponsored Conferences
H.R. 4631 Government Spending Accountability Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of Association for Molecular Pathology in Q32012 on Dec. 31, 2012.
Original Filing: 300525277.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Lobbying Issues
S.A. 2060 Government Sponsored Conferences
H.R. 4631 Government Spending Accountability Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on Oct. 17, 2012.
Original Filing: 300508357.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Lobbying Issues
S.A. 2060 Government Sponsored Conferences
H.R. 4631 Government Spending Accountability Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of Association for Molecular Pathology in Q22012 on Dec. 31, 2012.
Original Filing: 300525276.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
2nd Quarter, 2012
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on July 16, 2012.
Original Filing: 300484772.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
1st Quarter, 2012
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of Association for Molecular Pathology in Q12012 on Dec. 31, 2012.
Original Filing: 300525275.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
1st Quarter, 2012
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on April 17, 2012.
Original Filing: 300462075.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Patent & Trademark Office (PTO) Agency for Health Care Policy & Research
4th Quarter, 2011
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of Association for Molecular Pathology in Q42011 on Dec. 31, 2012.
Original Filing: 300525274.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Natl Institute of Standards & Technology (NIST)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
4th Quarter, 2011
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on Jan. 18, 2012.
Original Filing: 300440742.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Natl Institute of Standards & Technology (NIST)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
3rd Quarter, 2011
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. filed a lobbying registration on Dec. 30, 2012 to represent Association for Molecular Pathology, effective July 1, 2011.
Original Filing: 300525272.xml
Issue(s) they said they’d lobby about: Issues impacting the legislative and regulatory oversight of laboratory development, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics.
Genomics and Personalized Medicine Act; Genomic Research and Accessibility Act; BETTER Patient Care Act
HR 1249, America Invents Act .
3rd Quarter, 2011
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of Association for Molecular Pathology in Q32011 on Dec. 31, 2012.
Original Filing: 300525273.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, American Invents Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Natl Institute of Standards & Technology (NIST)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 1249, America Invents Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
3rd Quarter, 2011
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Association for Molecular Pathology , earning $30,000. The report was filed on Oct. 17, 2011.
Original Filing: 300415163.xml
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, American Invents Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Natl Institute of Standards & Technology (NIST)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care Act; HR 1249, America Invents Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
3rd Quarter, 2011
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. filed a lobbying registration on July 11, 2011 to represent Association for Molecular Pathology, effective July 1, 2011.
Original Filing: 300388251.xml
Issue(s) they said they’d lobby about: Issues impacting the legislative and regulatory oversight of laboratory development, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics.
Genomics and Personalized Medicine Act; Genomic Research and Accessibility Act; BETTER Patient Care Act
HR 1249, America Invents Act .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate